Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointments:

Gerard de Reuver (1956) at present Business Group Director DSM Anti Infectives (DAI), will be appointed Director Strategic Projects as per 1 March 2009, reporting to F. Sijbesma, Chairman of the DSM Managing Board. Gerard will be responsible for coordination and support of the program addressing the current economic circumstances and DSM’s change agenda.

Stefan Doboczky (1967) at present Business Unit Director DAI China, will succeed Gerard de Reuver as Business Group Director DAI as of 1 March 2009. Stefan has held various other management positions within the Pharma cluster before he joined DAI. He will report to Jan Zuidam, Deputy Chairman of the DSM Managing Board.